21 September 2023 in Journal of Bone and Joint Surgery
Background: Despite the fact that many synovial fluid biomarkers have found application in the routine diagnosis of periprosthetic joint infection (PJI), this process still remains a challenge for orthopaedic surgeons. To simplify this process, fast point-of-care (POC) tests can be used during ambulatory visits and in operating room conditions. However, before such tests can be routinely used in clinical practice, they require validation. The purpose of the present study was to evaluate the diagnostic accuracy of different fast POC tests for detecting C-reactive protein (CRP) in synovial fluid for the diagnosis of PJI. Methods: Synovial fluid samples were collected from 120 consecutive patients who underwent revision total joint arthroplasty (TJA). The patients were divided into 2 groups. The first group included 76 patients who underwent revision for reasons other than infection (the aseptic revision TJA [arTJA] group), and the second group included 44 patients who underwent revision because of periprosthetic joint infection (PJI). The diagnosis of infection was made according to the International Consensus Meeting (ICM) 2018 criteria. All patients were operatively treated at a single orthopaedic center from January 2022 to February 2023. Four fast CRP tests with different cutoff values (1 and 3 mg/L, ≥8 mg/L, ≥10 mg/L [cassette], ≥10 mg/L [strip]) were used off-label for synovial fluid testing. Tests were performed on the same synovial fluid samples, and the results of these tests were compared with those obtained with the laboratory method. Results: The cassette test with a minimum cutoff value of ≥8 mg/L demonstrated the best accuracy for the diagnosis of chronic PJI, with a sensitivity and specificity of 90.9% and 90.8%, respectively. For the cassette test with a cutoff value of >3 mg/L, the sensitivity and specificity were 68.2% and 77.6%, respectively. For the tests with a minimum cutoff value of ≥10 mg/L, the sensitivity and specificity were 77.3% and 94.7%, respectively, for the cassette test and 77.3% and 96.1%, respectively, for the strip test. The laboratory method with the statistically calculated threshold (2.7 mg/L) revealed the highest AUC (area under the receiver operating characteristic curve) value (0.95), with 90.9% sensitivity and 94.7% specificity. Conclusions: The cassette POC test with the minimum cutoff value of ≥8 mg/L had very good accuracy for the diagnosis of chronic PJI. This test had comparable sensitivity and slightly lower specificity in comparison with the laboratory method with the calculated threshold of 2.7 mg/L. Level of Evidence: Diagnostic Level III. See Instructions for Authors for a complete description of levels of evidence.
5 June 2025 in Diagnostic Microbiology and Infectious Disease
Among different, recently investigated biomarkers calprotectin (CLP) is one of the most promising indicator of periprosthetic joint infections (PJI). This study aims to evaluate the optimal cut-off values and efficacy of two (strip and cassette), semi-quantitative point-of-care (POC) tests detecting CLP for diagnosing chronic PJI. A total number of 98 patients (38 with PJI and 60 operated on due to aseptic reasons) were included in the analysis. All synovial fluid samples were tested off-label (synovial fluid samples were tested with tests dedicated to fecal samples) with two semiquantitative tests dedicated to CLP determination: (1) Actim® Calprotectin (strip) and (2) Accu-Tell® Calprotectin (cassette). The same cut-off values for both tests were possible to determine. Based on the calculated thresholds sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for diagnosing chronic PJI were calculated with statistical methods. For the Actim® Calprotectin (strip), for a positive result (≥+) sensitivity was 97.4 % (95 %CI=86.2-99.9), specificity was 81.7 % (95 %CI=69.6-99.9), PPV was 77 % (95 %CI=66.3-85.2) and NPV was 98 % (95 %CI=87.6-99.7). For the Accu-Tell® Calprotectin (cassette) test, for a positive result, (≥+) sensitivity, specificity, PPV, and NPV were 89.5 % (95 %CI=75.2-97.1), 90 % (95 %CI=79.5-96.2), 85 % (95 %CI=72.5-92.4), and 93.1 % (95 %CI=84.2-97.2), respectively. Both POC CLP tests have very good accuracy with off-label use on synovial fluid samples. After validation and adaptation these tests for liquid samples (synovial fluid), we believe these tests may be valuable support in routine clinical practice, especially in POC conditions.